Recently, a comparison of [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 for imaging of expression of HER2 in breast cancer has been reported (Bragina et al. 2023). Here, ERBB2 is linked to breast carcinoma.